Another Blow To Fauci: Hydroxychoroquine Study Debunks ‘Experts’ Cites His Research Showing It ‘Worked As An Anti…

Last year, President Trump was excoriated by Dr. Fauci and other experts for suggesting hydroxycholorquine (HCQ) could be used to treat COVID-19 patients. Well, a new study busts the Left and found that when used correctly HCQ “reduced the probability of Covid positivity by 34 per cent, 48 per cent and 72 per cent.”

The last wave of COVID hit the country of India really hard and at the recommendation of the “experts” in the west dropped the use of HCQ as a treatment for COVID. However, after the Union health minitry in Indian dropped HCQ there was some push back pointed out the lack of study-based evidence surrounding the drug and it’s effectiveness against COVID.

Researchers in India decided to use HCQ as a prophylactic (prevention) treatment and it was “the largest multicenter study on HCQ prophylaxis on HCWs (healthcare workers), covering over 12,000 HCWs at the risk of Covid-19”.

The study took place last year in May-September last year across 44 hospitals in 17 states and it involved the participations of hundreds of doctors.

One of the researchers even through HCQ back in Fauci’s lap highlighting the fact that “Dr Fauci wrote that HCQ worked an anti-viral agent despite being an anti-malarial drug. There was no Covid-19 back then. HCQ’s anti-viral properties were known.”

Below are some of the results reported by Dr. Raj Kamal Choudhry in the study:

“We did not give to those who had palpitations and had QT prolongation [a measure of heart ailment]. Those who took this drug did not have Covid excepting 5 and 6. The effect was tremendous. Later, we gave this drug to all who had mild cases. Only those patients who were in ICU were not given.”

“Of 2,700 people who were given HCQs, 700 were doctors. Only five or six got infected with SARS-CoV-2 in Bhagalpur but none developed serious complications, and nobody died of Covid-19.”

The findings of the study found that “HCQ is effective in reducing risk of Covid-19, at 800 mg loading and 400 mg weekly dose with more than 2 weeks dosing.”

Researchers said that the vaccine has its “limitations” and that HCQ can be an alternative strategy to prevent or curb serious cases.

Yahoo News